Chapter 30: Respiratory Tract Infections, Neoplasms, and Childhood Disorders

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive, our mission today to really boil down the essentials on the path of

OK,

let's get into it.

Yeah, and it's serious stuff right from the start.

I mean, respiratory illnesses aren't just annoying.

They account for a huge chunk of doctor visits and keep people from their daily lives.

And the impact is massive.

Think about this.

Pneumonia is the eighth leading cause of death here in the U .S.

and it's the third leading cause of

and TB tuberculosis still affects roughly a third of the entire world's population.

It's staggering.

Wow, a third.

Yeah, TB and pneumonia alone really show why this topic is so critical.

We need to connect these stats to what's actually happening at a molecular level and what signs you need to spot.

So let's start with the common invaders.

Respiratory tract infections, the common cold, for instance, usually rhinovirus, right?

But how does it actually, you know, get in?

Right.

The mechanism is specific.

These viruses, they latch onto something called the intercellular adhesion molecule, or ACAM -1.

Think of it as a docking station on our cells.

Once they bind, they're in.

And that binding, that mechanism, it points to something important about how it spreads.

We tend to think it's all sneezing, all aerosol.

Well, yes and no.

The surprising thing is the main way it spreads isn't actually breathing in droplets.

The evidence points much more strongly to fingers.

You touch a contaminated surface, a doorknob, a phone, whatever, then you touch your nose or rub your eyes, and bam, the virus transfers to the nasal mucosa or conjunctiva.

It's really a hand -to -face disease, mostly.

Okay, good reminder for hand washing.

Symptoms are pretty familiar.

That initial dryness or stuffiness,

then the runny nose, clear, watery stuff, usually post -nasal drift, sore throat, just feeling generally unwell.

And since it's viral, treatment is just managing symptoms.

But there's a key warning about over -the -counter decongestants, isn't there?

Who needs to be careful?

Absolutely.

Those decongestants, they're sympathomimetic agents, meaning they mimic the sympathetic nervous system and cause vasoconstriction tightening of blood vessels systemically all over the body.

So if you already have high blood pressure, heart disease, or diabetes, that systemic squeeze can push your blood pressure up dangerously and put extra strain on your heart.

It's a risk people often don't think about for a simple cold medicine.

Good point.

Okay, moving slightly up the airway, rhinosinusitis.

Inflammation in the sinuses, those air pockets in the skull.

The issue here is more about plumbing, right?

Anatomy.

Exactly.

The sinuses are designed to drain.

They produce mucus and tiny hairs, cilia, sweep it out through these narrow little openings called ostia into the nasal cavity.

It relies on that mucociliary clearance working properly.

But if those ostia get blocked maybe from swelling due to a viral cold or allergies or even nasal polyps, everything backs up.

The mucus gets stagnant and that's a perfect breeding ground for infection.

That's the basic problem.

So clinically, how do you tell the difference between a simple viral blockage that'll clear up and a bacterial infection needing antibiotics?

Time is usually the best clue.

Acute viral rhinosinusitis.

It tends to get better on its own in about five to seven days.

But if the symptoms suddenly get worse after five or seven days, or if they just drag on for more than 10 days, that's when you suspect acute bacterial rhinosinusitis.

Look for specific signs too, like pain focused on one side over the maxillary sinus or pain that gets worse when you bend forward.

The usual culprits are bacteria like H influenza or S pneumonia.

We see sinusitis treated all the time.

It feels pretty routine.

But are there like really serious complications we should be aware of, even if they're rare?

There are.

And it's all about location, location, the sinuses, especially the frontal and ethmoid ones are right next door to the brain in the orbit, the eye socket.

So although it's uncommon, a severe sinus infection can potentially spread, leading to orbital cellulitis infection around the eye or even dangerous intracranial problems like brain abscesses.

It justifies taking severe cases seriously.

Right.

Okay.

Let's shift to a major player.

Influenza.

The flu and orthomixovirus RNA type.

Yeah.

When we talk about how it works and spreads, those two surface proteins are key aren't they?

HA and NA.

They're absolutely critical.

They're the viruses tools of the trade.

Hemagglutinin or HA is like the key it lets the virus attach to and enter our respiratory cells.

And neuraminidase, NA, that's needed later, it helps the newly replicated viruses get out of the infected cell so they can spread.

And the reason we need flu shots every year is because these proteins change.

Can you explain the difference between drift and shift?

Sure.

Antigenic drift refers to the small gradual changes, minor mutations that happen all the time in the HA and NA genes.

This is why immunity from a previous flu or vaccine might not be perfect the next year.

Your immune system might only partially recognize it.

Antigenic shift though, that's the big one.

That's a major abrupt change, usually when different influenza virus strains like one from birds or pigs and one from humans infect the same host and exchange large chunks of genetic material.

This creates a completely novel subtype that human immune systems have never seen before.

That's what leads to pandemics because there's virtually no pre -existing immunity in the population.

And the illness itself,

it's pretty destructive at the cellular level, isn't it?

It goes after those ciliated cells lining the airway.

It does.

The virus specifically targets and kills them.

This has a couple of major consequences.

First,

destroying that protective layer of ciliated cells leaves the underlying tissue exposed.

Fluid leaks out.

That's your classic, profuse, watery, runny nose characteristic of flu.

Second, stripping away that natural barrier makes it easier for bacteria to stick around and invade.

That's why influenza often paves the way for a secondary bacterial pneumonia, which can be very serious.

Clinically, if someone feels awful, how can you strongly suspect flu over just a really bad cold?

What's the giveaway?

The abruptness and the systemic nature of the symptoms.

With flu, you typically get hit suddenly, pow, with high fever, chills, maybe even shaking rigors, muscle aches, headache, and this overwhelming fatigue or malaise.

It really knocks you flat.

Colds tend to come on more gradually, and complications are a real worry.

You can get primary viral pneumonia directly from the flu virus itself, which can progress terrifyingly fast, or you might start feeling a bit better, and then bam, fever and chills return.

That often signals a secondary bacterial pneumonia setting in.

Okay, let's move deeper now, down into the lower airways in the lung tissue itself.

Let's talk pneumonia inflammation of the parenctoma, the alveoli, and bronchioles.

Classification can seem tricky, so what are the most useful ways to categorize it?

Yeah, it helps to break it down.

First, think about where the patient likely got it.

Is it community -acquired pneumonia?

CIP.

This is the most common type, often caused by streptococcus pneumonia.

Or is it hospital -acquired pneumonia, HAP, also called nosocomial?

This develops 48 hours or more after someone's admitted to the hospital.

HAP generally has a higher death rate, partly because the bacteria involved, like Pseudomonas aeruginosa or MRSA, are often more resistant to antibiotics.

Okay, so setting is one way.

What about the type of germ involved, typical versus atypical?

Right.

Typical pneumonias are usually caused by bacteria, like pneumococcus, that live and multiply outside of our cells in the alveolar spaces.

They trigger a big inflammatory response with lots of fluid, and pus exudate filling the alveoli.

Atypical pneumonias, on the other hand, are often caused by viruses or bacteria, like mycoplasma or chlamydia, that tend to invade the lung tissue itself, the alveolar walls, the interstitium.

The inflammation is more inside the tissue structure, often leading to less dramatic symptoms, maybe more like a bad cough, headache, muscle aches, sometimes called walking pneumonia.

Let's focus on that classic, typical one, pneumococcal pneumonia.

You mentioned distinct stages of pathology.

Yes.

The lung tissue goes through phases.

It starts with edema, then progresses to what's called red hepatization.

Hepatization means liver -like.

In this stage, the air sacs fill up with red blood cells, white blood cells, and fibrin, making that part of the lung solid, dense, and reddish, kind of like liver tissue.

Then it moves to gray hepatization.

As the still firm.

Finally, if all goes well, resolution occurs as macrophages clear the debris.

And this process creates a pretty distinct clinical picture.

It often does.

Classic pneumococcal pneumonia frequently presents with a sudden onset, shaking shills, high fever, chest pain that worsens with breathing, pleuritic pain, and often a cough -producing sputum that's described as rust -colored or blood tinged.

That rust color is from the breakdown of red blood cells in the exudate.

Got it.

We should also quickly mention Legionnaires' disease.

Different bug.

Legionella pneumophilus spread differently too, right?

Yes.

Legionnaires is typically acquired by inhaling aerosolized water contaminated with the bacteriothin cooling towers, large plumbing systems, fountains, that sort of thing.

Not person -to -person spread.

And clinically, you should look for a specific cluster of signs.

The classic triad for Legionnaires is pneumonia plus diarrhea plus hyponatremia, low sodium levels, and often confusion.

Seeing those together should definitely make you suspect Legionella.

Okay, that focus on host defense is a good segue into tuberculosis.

Caused by mycobacterium tuberculosis,

these bacteria have a preference for a certain part of the lung.

They do.

Tuberculosis are strict aerobes.

They need oxygen to thrive.

And the highest oxygen concentration in the lungs is typically in the apices, the upper lobes.

So that's where primary or reactivated TB infections are often found.

And the way our body handles them is unique.

It's about immune evasion initially.

Exactly.

When you inhale the droplet nuclei containing the bacilla, macrophages in your lungs engulf them.

But the TB bacillus has this waxy outer coat that prevents the macrophages lysosomes, its internal killing machinery, from fusing with the compartment containing the bacteria, the phagosome.

So the bacteria can survive and even multiply inside the macrophages for a while, hidden from the main immune attack.

But eventually the immune system does respond.

It tries to contain it.

Yes, it takes about three to six weeks, but your cell -mediated immunity kicks in.

Specialized immune cells, T lymphocytes, get activated.

They surround the infected macrophages, forming a granuloma, a sort of microscopic wall.

This initial granuloma in the lung tissue is called the gon focus.

If the infection also spreads to the nearby lymph nodes and forms granulomas there, the combination of the lung lesion and the lymph node lesion is called the gon complex.

In most healthy people, this gon complex eventually heals and calcifies, containing the bacteria.

This leads to latent TB infection.

The person is infected but not sick and can't spread it.

But the crucial point is those walled off bacteria can remain viable, dormant for years, even decades.

Which means it can reactivate later if immunity weakens.

Precisely.

Now about diagnosis, the PPD skin test, the tuberculin test, what does a positive result actually mean?

This is super important.

A positive PPD tells you that the person has been exposed to TB at some point and has developed cell -mediated immunity to it.

It indicates immunity or past infection.

It does not tell you if the person has active infectious TB disease right now.

And there's a critical caveat.

People who are severely immunocompromised, say with advanced HIV or on certain immunosuppressant drugs, might not be able to mount an immune response even if they are infected.

So they can have a false negative PPD test.

This is called energy.

Okay, very important distinction.

Let's quickly touch on fungal infections of the lung before we move on.

These often have geographical ties, right?

Yeah.

And a unique characteristic.

Yes.

Many serious fungal lung infections are caused by fungi that are dimorphic.

That means they exist in one form, usually a mold in the environment, like soil or organic debris.

But when their spores are inhaled and reach body temperature inside the lungs, they convert into a different form, typically a yeast.

And where you live or travel matters.

Give us the main players.

Okay, three big ones to know by region.

Histoplasmosis, caused by Histoplasma capsulatum, is common in the Ohio and Mississippi River valleys.

Think areas with lots of bird or bat droppings as the fungus thrives there.

Then there's blastomycosis from blastomyces dermatitis, found more in the soil of the south, central, southeastern, and midwestern U .S., often near rivers.

Clinically, the cough with blasto is often productive, maybe purulent, which can differ from histo.

And coccidioidomycosis, or valley fever, caused by coccidioides imidus, or C.

posidasi.

This one's endemic to the desert regions of the southwestern U .S., California, Arizona, etc.

Ah, valley fever.

I remember hearing something interesting about its symptoms and what they imply about the patient's immune system.

Yes, that's a fascinating point.

With coccidioidomycosis, if a patient develops certain extra pulmonary signs, specifically skin lesions, often called desert thumps, erythema or nodosum, and joint pain known as desert rheumatism, or desert arthritis,

it sounds bad, but it actually indicates a strong cell -mediated immune response.

It means the body is effectively fighting and containing the fungus, preventing it from disseminating widely, which would be much more dangerous.

So those peripheral signs are, paradoxically, often a good prognostic indicator.

Interesting.

Okay, that theme of host vulnerability and chronic damage sets us up perfectly to talk about lung cancer.

Sadly, the leading cause of cancer death globally, and smoking is the elephant in the room.

Absolutely.

Cigarette smoking is linked to, what, over 80 % of lung cancer cases.

Other factors exist, like asbestos exposure, radon, genetics, but smoking is by far the biggest risk factor.

For thinking about prognosis and treatment, the main split is small cell versus non -small cell, right?

Exactly.

That's the fundamental division.

Small cell lung cancer, SCLC, makes up maybe 15 -20 % of cases.

It's very aggressive, grows rapidly, and metastasizes early and widely.

It's almost exclusively seen in smokers.

By the time it's diagnosed, it's often already spread frequently to the brain.

And lung cancers, particularly SCLC, are notorious for causing those weird, distant effects, the perineoplastic syndrome.

Yes.

This is where it gets biologically fascinating.

The tumor cells themselves start producing hormones or hormone -like substances they shouldn't be making, or they trigger autoimmune responses.

These can cause all sorts of endocrine, neurologic, or metabolic problems that seem unrelated to the lung tumor itself.

Can you give us the classic associations?

What syndrome should make us think SCLC?

For SCLC, the two most famous perineoplastic syndromes are SIADH, the syndrome of inappropriate antidiuretic hormone secretion, which causes hyponatremia, low sodium, and ectopic production of ACTH, leading to Cushing syndrome.

Seeing those biochemically should wing alarm bells for SCLC.

Okay.

What about the non -small cell lung cancers?

NSCLC, that's the bigger group.

Right.

NSCLC is the umbrella term for the other types, mainly adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

Let's focus on squamous cell and adeno.

Any key links there?

Squamous cell carcinoma is very strongly linked to smoking.

It typically arises centrally in the larger bronchi.

Because it's central, it might cause symptoms like coughing or hemoptysis earlier, and sometimes malignant cells can be found in sputum cytology.

The classic perineoplastic syndrome associated with squamous cell is hypercalcemia, due to the tumor producing a parathyroid hormone -related peptide.

Adenocarcinoma is now actually the most common type overall, especially in women and non -smokers, though smoking still increases risk.

It tends to arise more peripherally in the lung, sometimes new areas of scarring.

It doesn't have as strong a single perineoplastic link as the others.

The tragedy with lung cancer, though, is that the initial symptoms are often so vague, right?

Things like loss of appetite, weight loss, maybe a chronic cough.

Exactly.

They often mimic symptoms of other chronic lung conditions like COPD or bronchitis.

This unfortunately means diagnosis is often delayed until the cancer is quite advanced and has already metastasized, commonly to the brain, bones, liver, or adrenal glands.

And given that lung cancer is often diagnosed in older adults.

That's a crucial point for management.

The average age at diagnosis is around 70.

Treatment decisions, whether surgery, chemo, radiation, immunotherapy,

absolutely must be based on the patient's physiologic age, their overall health, their functional status, and their own goals of care, not just their chronological age on paper.

Right.

Focusing on the whole patient.

That idea of functional status and vulnerability brings us nicely to our last major area,

respiratory disorders in children.

Their smaller airways just change the whole game, don't they?

They absolutely do.

An amount of inflammation or mucus that might just cause a cough in an adult can cause severe, even life -threatening obstruction in an infant or small child, simply because their airways are so much narrower to begin with.

And this vulnerability starts really early, even before birth, with lung development.

Yes, the lungs are one of the last organ systems to fully mature.

A critical step is the production of surfactant.

This is a substance made by specialized cells in the alveoli, the type 2 pneumocytes, that reduces surface tension and prevents the tiny air sacs from collapsing completely when you exhale.

Production of surfactant doesn't really ramp up until later in gestation, maybe starting around 24 weeks and becoming adequate closer to 30, 35 weeks.

So if a baby is born very prematurely.

Before they're making enough surfactant, they develop respiratory distress syndrome, RDS, previously called high -line membrane disease.

Their alveoli collapse with each breath out, making breathing incredibly difficult and inefficient.

It's a primary problem of lung immaturity.

And you can actually hear signs of this distress, can't you?

Like grunting.

Yes, the signs are key.

In restrictive problems like RDS, where the lungs are stiff and hard to inflate, infants tend to breathe faster, to Chypnea, and shallower.

You might hear expiratory grunting.

That grunting sound is actually the baby partially closing their glottis, the opening of the voice box, during exhalation.

They're instinctively trying to trap air in their lungs, increasing the pressure at the end of expiration, like peep, to try and keep those unstable alveoli from collapsing.

What other signs indicate increased work of breathing?

You'll see nasal flaring, they widen their nostrils to try and decrease airway resistance.

You'll see retractions sucking in of the soft tissues between the ribs, below the ribs, or above the collarbones, showing they're using accessory muscles to pull air in.

And then there are the sounds.

Stridor is a high -pitched, harsh, crowing sound, usually heard best on inspiration.

It indicates an obstruction outside the chest cavity, high up in the airway, think larynx or trachea.

Class example is croup.

Wheezing, on the other hand, is more of a whistling or musical sound, usually heard best during a prolonged expiration.

It points to obstruction inside the chest cavity and the smaller airways, the bronchioles.

Classic example is bronchiolitis.

Okay, let's talk about those specific pediatric infections.

Crump, acute, laryngeotracheal bronchitis.

You mentioned stridor.

What's the other classic sign?

The barking cough.

It really sounds like a seal barking.

That plus the inspiratory stridor and some hoarseness.

It's usually viral, causing inflammation and swelling, mainly in the subglottic area, just below the vocal cords.

Parents often notice the symptoms seem worse at night and might improve dramatically if they take the child out into the steamy bathroom.

The cold or moist air can help reduce the swelling.

Okay, contrast that with epiglottitis, much scarier.

Oh, absolutely.

Epiglottitis is a true medical emergency.

It's a bacterial infection,

classically hemophilus influenza type B, though less common now due to the high of vaccine, causing rapid severe inflammation and swelling of the epiglottis and surrounding structures above the vocal cords, the supraglottic area.

This can completely block the airway very quickly.

The child often looks acutely ill, pale, toxic, very anxious.

They typically sit bolt upright, leaning forward, chin thrust out the tripod position, struggling to breathe.

They often have difficulty swallowing, leading to drooling, and their voice might sound muffled.

And there's a critical warning here about examining them.

Yes, critical clinical alert.

If you suspect epiglottitis, never ever try to force the child to lie down and absolutely do not attempt to examine their with a tongue depressor or anything else.

Doing so can trigger laryngeal spasm or cause the swollen epiglottis to completely occlude the airway instantly, leading to respiratory arrest and potentially cardiac arrest.

It's a hands -off situation until you're in a controlled setting, like an OR, ready to secure the airway.

Life and death important.

Understood.

Extremely vital point.

Lastly, acute bronchiolitis affects the smaller airways.

Yes, this is primarily an illness of infants and very young children, most often caused by respiratory syncytial virus or RSV.

It causes inflammation and necrosis cell death of the lining of the small airways, the bronchioles.

This leads to mucus plugging and airway narrowing, which particularly affects expiration.

Air gets trapped in the lungs, hyperinflation, expiration becomes prolonged, and you typically hear that characteristic wheezing along with seeing retractions into chipnia.

So with all these conditions, how do we know when a child is moving from respiratory distress to outright respiratory failure?

What are the signs of impending collapse?

You look for signs that their compensatory mechanisms are failing.

Things like severe retractions and grunting getting worse,

cyanosis, bluish discoloration, that doesn't improve even with supplemental oxygen, say 40 % have it too.

A heart rate that becomes extremely fast, over 150 BPM in an infant, or more ominously, starts to slow down, bradycardia,

extreme agitation, or conversely, lethargy and decreased responsiveness, or significant changes in breathing rate, either very rapid and shallow or slowing down with periods of apnea, pauses in breathing.

These are all red flags indicating imminent failure.

Okay, so wrapping this all up, what's the big picture here?

We've gone from viruses latching on to ICAM -1 through the devastating potential of antigenic shift, looked at how we classify pneumonias and cancers, the unique immune battle in TB, and landed on the specific vulnerabilities of tiny airways in leading to things like RDS and epiglottitis.

I think a really powerful final thought linking many of these threads is just how often a compromised host defense is the critical factor.

Whether it's the immaturity of the immune system in a premature infant leading to RDS, the weakened immunity in an HIV patient allowing TB reactivation or atypical pneumonia,

the effects of age or chronic illness making someone susceptible to severe influenza or bacterial pneumonia,

or even immunosuppressive therapy opening the door to fungal infections.

So often the severity of respiratory disease hinges on the state of the patient's own immune system.

It really emphasizes the need for critical thinking you have to connect the pathogen or the disease process with the specific vulnerabilities of the host sitting in front of you.

That's a great point to end on.

It highlights the interplay we always need to consider.

Thank you for joining us for this deep dive into respiratory pathophysiology.

We hope this summary helps you connect the dots and apply this crucial knowledge.

This has been a last minute lecture team summary.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Respiratory tract pathology encompasses a diverse array of conditions ranging from self-limited viral infections to life-threatening bacterial pneumonias, fungal invasions, and malignant neoplasms that require distinct diagnostic and therapeutic approaches. Acute upper respiratory infections, particularly those caused by rhinoviruses and influenza viruses, initiate pathogenic processes through viral attachment and replication within epithelial cells, triggering innate immune responses that produce both protective and symptomatic effects. Bacterial infections of the paranasal sinuses and nasal passages develop when normal drainage mechanisms fail or pathogens overcome mucosal defenses, resulting in rhinosinusitis with potential for intracranial or orbital complications if untreated. Pneumonia classification depends on acquisition context, with community-acquired cases typically involving streptococcus pneumoniae and haemophilus influenzae, while nosocomial pneumonias in hospitalized and immunocompromised patients arise from different microbial flora including pseudomonas and gram-negative organisms. Atypical pathogens such as legionella species and chlamydia organisms produce distinct clinical presentations with minimal respiratory findings despite significant radiographic involvement, often requiring macrolide or fluoroquinolone therapy. Deep fungal infections, particularly histoplasmosis acquired through environmental exposure to fungal spores, demonstrate tissue invasion patterns and host immune responses distinct from bacterial pneumonias, with special considerations for immunocompromised populations. Malignant transformation of respiratory epithelium occurs through accumulation of genetic mutations, with tobacco exposure and chronic inflammation serving as major carcinogenic drivers in lung cancer development. Pediatric respiratory conditions present unique management challenges due to anatomical differences including smaller airways and developing immune competence, affecting both disease severity and therapeutic options. Understanding the pathophysiological mechanisms underlying each respiratory condition enables clinicians to anticipate complications, select appropriate antimicrobial or anticancer therapies, and implement preventive strategies that reduce disease transmission and morbidity.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥